These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21781012)

  • 1. A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial.
    Bassiri-Jahromi S; Ehsani AH; Mirshams-Shahshahani M; Jamshidi B
    J Dermatolog Treat; 2012 Dec; 23(6):453-6. PubMed ID: 21781012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis.
    Baran R; Coquard F
    J Dermatolog Treat; 2005 Feb; 16(1):52-5. PubMed ID: 15897169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
    Drake L; Babel D; Stewart DM; Rich P; Ling MR; Breneman D; Scher RK; Martin AG; Pariser DM; Pariser RJ; Ellis CN; Kang S; Katz HI; McDonald CJ; Muglia J; Savin RC; Webster G; Elewski BE; Leyden JJ; Bucko AD; Tschen EH; Hanifin JM; Morman MR; Shupack JL; Greer DL
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S87-94. PubMed ID: 9631990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
    Scher RK; Breneman D; Rich P; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S77-86. PubMed ID: 9631989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
    Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
    J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.
    Ling MR; Swinyer LJ; Jarratt MT; Falo L; Monroe EW; Tharp M; Kalivas J; Weinstein GD; Asarch RG; Drake L; Martin AG; Leyden JJ; Cook J; Pariser DM; Pariser R; Thiers BH; Lebwohl MG; Babel D; Stewart DM; Eaglstein WH; Falanga V; Katz HI; Bergfeld WF; Hanifin JM; Young MR
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S95-102. PubMed ID: 9631991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.
    Tietz HJ; Hay R; Querner S; Delcker A; Kurka P; Merk HF
    Mycoses; 2013 Jul; 56(4):414-21. PubMed ID: 23586591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Schaller M; Sigurgeirsson B; Sarkany M
    Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical avulsion with urea nail lacquer.
    Baran R; Tosti A
    J Dermatolog Treat; 2002 Dec; 13(4):161-4. PubMed ID: 19753735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis.
    Havu V; Heikkilä H; Kuokkanen K; Nuutinen M; Rantanen T; Saari S; Stubb S; Suhonen R; Turjanmaa K
    Br J Dermatol; 2000 Jan; 142(1):97-102. PubMed ID: 10651701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with ciclopirox lacquer of onychomycoses caused by molds].
    Ulbricht H; Wörz K
    Mycoses; 1994; 37 Suppl 1():97-100. PubMed ID: 7854374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.
    Schalka S; Nunes S; Gomes Neto A
    An Bras Dermatol; 2012; 87(1):19-25. PubMed ID: 22481647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
    Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
    Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
    Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
    Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.